MENU
NGENF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
NervGen Pharma (NGENF) Ownership - Who owns NervGen Pharma?
NervGen Pharma Corp principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease... Show more
Profile
Industry
N/A
Address
112-970 Burrard Street
Phone
+1 778 731-1711
Employees
N/A
Web
https://www.nervgen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
161.21M
P/E Ratio
N/A
Total Cash
21.01M
Projected Growth
N/A
Total Debt
129.02K
Revenue
N/A
Risk (Beta)
0.89
Dividend Yield
N/A
Total Cash/Share
0.30
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NGENF
Capitalization
161M
P/E Ratio
N/A
Risk (Beta)
0.89
Dividend Yield
N/A
Total Cash
21M
Total Cash/Share
0.30
Total Debt
129K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
9.18M
P/B Ratio
25.00
Cash Flow
N/A
Earnings
-0.38
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
80.5M
Current Ratio
1.66
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-27.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-123.68
Shares Held By Institutions
0
Shares Outstanding - Current
70.3M
Total Liabilities
13.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
4.128
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
112-970 Burrard Street
Phone
+1 778 731-1711
Employees
N/A
Web
https://www.nervgen.com